≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Meningitis

EFO Endpoint Browser PheWeb

MENINGITIS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

1936

6. Filter based on genotype QC (FinnGen only)

1936

Control definitions (FinnGen only)

Control exclude
AB1_VIRAL_CNS

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 18175 8439 9598
Only index persons 14933 7258 7675
Unadjusted period prevalence (%)
Whole population 0.25 0.24 0.27
Only index persons 0.28 0.27 0.29
Median age at first event (years)
Whole population 29.98 32.14 27.70
Only index persons 26.99 29.97 24.16

-FinnGen-

Key figures

All Female Male
Number of individuals 1936 1088 848
Unadjusted period prevalence (%) 0.37 0.37 0.37
Median age at first event (years) 33.45 32.38 34.83

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1744
Matched controls
17441
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
32099
ICD-8 Finland
Meningitis, With no organism specified as cause
+∞
323.0
335
*
G03.9
ICD-10 Finland
Meningitis, unspecified
+∞
323.0
362
*
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
+∞
275.5
257
*
32088
ICD-8 Finland
Meningitis, Alia definita
+∞
191.2
180
*
A87.9
ICD-10 Finland
Viral meningitis, unspecified
2042.1
183.6
175
*
TAB00
NOMESCO Finland
Lumbar puncture
10.1
135.7
286
331
32000
ICD-8 Finland
Meningitis, H. influenzae
+∞
106.3
101
*
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
958.1
93.8
91
*
3229X
ICD-9 Finland
Meningitis of unspecified cause, Meningitis, unspecified
+∞
83.0
79
*
G00.1
ICD-10 Finland
Pneumococcal meningitis
+∞
81.9
78
*
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
78.7
75
*
AA1AD
NOMESCO Finland
CT of head and brain
2.8
62.1
501
2205
R51.80
ICD-10 Finland
Headache
3.1
59.6
392
1507
A86
ICD-10 Finland
Unspecified viral encephalitis
+∞
54.5
52
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.9
52.0
234
666
G01*A39.0
ICD-10 Finland
Meningococcal meningitis
+∞
40.8
39
*
G03.0
ICD-10 Finland
Nonpyogenic meningitis
+∞
39.7
38
*
G03.8
ICD-10 Finland
Meningitis due to other specified causes
+∞
36.6
35
*
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
48.5
31.6
38
8
AAF00
NOMESCO Finland
Ventriculostomy
15.7
30.0
49
32
G03.1
ICD-10 Finland
Chronic meningitis
+∞
29.2
28
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
29.2
279
1285
G00.2
ICD-10 Finland
Streptococcal meningitis
+∞
28.2
27
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
48.0
27.5
33
7
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
10.5
26.6
52
51
G02.0*B02.1
ICD-10 Finland
Zoster meningitis
+∞
26.1
25
*
R50.9
ICD-10 Finland
Fever, unspecified
2.3
26.0
273
1314
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.7
25.6
90
201
G00.8
ICD-10 Finland
Other bacterial meningitis
+∞
25.1
24
*
0499X
ICD-9 Finland
Other non-arthropod-borne viral diseases of central nervous system, Unspecified non-arthropod-borne viral diseases of central nervous system
+∞
25.1
24
*
G02.0
ICD-10 Finland
Meningitis in viral diseases classified elsewhere
+∞
25.1
24
*
G00.3
ICD-10 Finland
Staphylococcal meningitis
+∞
25.1
24
*
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
14.4
24.4
41
29
N71
ICPC
Meningitis/encephalitis
+∞
24.0
23
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
23.8
244
1156
3209X
ICD-9 Finland
Bacterial meningitis, Meningitis due to unspecified bacterium
+∞
23.0
22
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
21.9
683
4839
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
18.7
21.7
33
18
G02.0*B01.0
ICD-10 Finland
Varicella meningitis
+∞
20.9
20
*
A69.2
ICD-10 Finland
Lyme disease
3.2
20.8
112
364
5AB01
NOMESCO Finland
NA
77.8
20.7
23
*
G01*A32.1
ICD-10 Finland
Listerial meningitis
+∞
19.8
19
*
G01
ICD-10 Finland
Meningitis in bacterial diseases classified elsewhere
+∞
19.8
19
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.9
19.3
120
429
G91.0
ICD-10 Finland
Communicating hydrocephalus
13.4
19.2
33
25
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
19.2
168
734
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
18.8
344
2047
G02.0*A87.0
ICD-10 Finland
Enteroviral meningitis
+∞
18.8
18
*
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
70.7
18.7
21
*
R51
ICD-10 Finland
Headache
2.8
18.1
120
448
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
8.5
18.0
39
47
J05AB11
ATC
valaciclovir; oral
2.0
17.9
234
1228
A87.8
ICD-10 Finland
Other viral meningitis
+∞
17.7
17
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
17.5
152
661
04599
ICD-8 Finland
Aseptic mentingitis due to enterovirus, Aseptic meningitis, unspecified
+∞
16.7
16
*
32010
ICD-8 Finland
Meningitis, Pneumococcus
+∞
16.7
16
*
G03.2
ICD-10 Finland
Benign recurrent meningitis [Mollaret]
+∞
16.7
16
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
16.5
261
1473
N03AX14
ATC
levetiracetam; systemic
3.9
16.0
66
174
N03AX16
ATC
pregabalin; oral
1.7
16.0
384
2479
G51.0
ICD-10 Finland
Bell palsy
3.9
15.9
65
170
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
6.7
15.9
40
61
N02AX02
ATC
tramadol; systemic, rectal
1.5
14.7
654
4925
N03AX12
ATC
gabapentin; oral
1.9
14.7
251
1450
3200A
ICD-9 Finland
Bacterial meningitis, Haemophilus meningitis
+∞
14.6
14
*
A39.0
ICD-10 Finland
Meningococcal meningitis
+∞
14.6
14
*
H02AB06
ATC
prednisolone; systemic
1.5
14.5
740
5740
J05AB01
ATC
aciclovir; systemic
1.7
14.4
335
2134
R42
ICD-10 Finland
Dizziness and giddiness
1.7
14.1
324
2057
SPAT1255
SPAT
Intravenous administration of medicine
2.5
13.8
113
477
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
12.1
13.6
24
20
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
6.6
13.6
34
52
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
141.1
13.5
14
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.0
13.3
76
259
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
22.7
12.9
18
8
XA800
NOMESCO Finland
Neuropsychological investigation
2.7
12.8
88
337
G00.0
ICD-10 Finland
Haemophilus meningitis
130.9
12.4
13
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.6
12.4
89
350
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
4.5
12.1
42
95
N02BE01
ATC
paracetamol; systemic, rectal
1.5
12.0
1382
12449
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
11.9
326
2165
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.8
11.9
49
131
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
11.8
553
4158
WX882
NOMESCO Finland
High dependency care
3.3
11.8
58
179
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
4.8
11.7
38
81
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.7
11.6
78
297
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
6.2
11.5
30
49
3201A
ICD-9 Finland
Bacterial meningitis, Pneumococcal meningitis
+∞
11.5
11
*
B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
11.5
11
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.9
11.4
46
121
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
11.3
812
6627
H02AB07
ATC
prednisone; oral
1.8
11.3
218
1307
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
15.1
11.3
18
12
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
11.3
273
1749
N03AF02
ATC
oxcarbazepine; oral
2.9
11.2
66
232
A41.9
ICD-10 Finland
Sepsis, unspecified
3.1
11.1
61
204
G44.2
ICD-10 Finland
Tension-type headache
1.7
10.9
219
1331
N03AB02
ATC
phenytoin; systemic
5.6
10.7
30
54
J01DB01
ATC
cefalexin; oral
1.5
10.7
1345
12128
G91.1
ICD-10 Finland
Obstructive hydrocephalus
8.0
10.6
23
29
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.2
10.6
39
95
N05CF01
ATC
zopiclone; oral
1.5
10.5
465
3444
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
10.4
406
2920
A87.0
ICD-10 Finland
Enteroviral meningitis
+∞
10.4
10
*
B00.4
ICD-10 Finland
Herpesviral encephalitis
+∞
10.4
10
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
10.4
244
1550
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
10.2
148
804
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
10.2
336
2330
N06AA09
ATC
amitriptyline; systemic
1.9
9.9
154
860
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
9.9
155
867
A02BC02
ATC
pantoprazole; systemic
1.4
9.9
982
8413
J01AA02
ATC
doxycycline; systemic
1.4
9.7
1229
10963
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
5.6
9.7
27
49
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
9.6
100
478
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
8.4
9.6
20
24
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
15.1
9.5
15
10
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
9.4
548
4262
ABE50
NOMESCO Finland
Occipitocervical decompression
100.6
9.4
10
*
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
100.6
9.4
10
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
9.4
564
4414
G63.0*A69.2
ICD-10 Finland
Polyneuropathy (in) Lyme disease
21.8
9.3
13
6
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
9.3
95
450
H53.2
ICD-10 Finland
Diplopia
3.0
9.3
53
182
WX730
NOMESCO Finland
Conventional respirator
4.7
9.2
30
65
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
9.2
288
1970
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.0
9.1
35
89
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
6.7
9.1
22
33
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.6
9.1
65
256
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
36.9
9.0
11
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
9.0
78
344
N73
ICPC
Neurological infection other
24.1
8.9
12
5
N01
ICPC
Headache
1.8
8.9
169
1007
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
8.8
84
385
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.9
8.8
120
641
J01FF01
ATC
clindamycin; systemic
1.4
8.8
408
3034
B34.9
ICD-10 Finland
Viral infection, unspecified
2.9
8.8
51
178
AA1AA
NOMESCO Finland
Head X-ray examination
6.4
8.8
22
35
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
8.7
395
2922
J01DA01
ATC
[U] cefalexin; systemic
1.4
8.7
981
8498
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
7.7
8.6
19
25
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
8.6
337
2421
AAF15
NOMESCO Finland
Ventriculoatrial shunt
11.6
8.6
15
13
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
3.9
8.4
33
86
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
8.4
119
644
J01EA01
ATC
trimethoprim; systemic
1.5
8.4
349
2534
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.2
8.4
42
134
B02.1
ICD-10 Finland
Zoster meningitis
+∞
8.3
8
*
N03AG01
ATC
valproic acid; systemic, rectal
2.0
8.3
102
524
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
8.2
696
5744
N03AF01
ATC
carbamazepine; oral, rectal
2.1
8.1
85
409
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
8.1
93
464
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
8.1
260
1786
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.6
7.9
191
1220
R03AC02
ATC
salbutamol; inhalant
1.3
7.9
806
6828
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
7.8
425
3244
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
7.8
159
969
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
4.5
7.8
26
59
P01BA02
ATC
hydroxychloroquine; oral
1.8
7.7
120
671
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
7.6
108
583
ZXC95
NOMESCO Finland
Use of surgical navigator
4.0
7.6
28
70
A32.7
ICD-10 Finland
Listerial sepsis
25.1
7.6
10
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.8
7.6
48
177
ZX120
NOMESCO Finland
Intravenous
1.8
7.5
137
809
J01CA04
ATC
amoxicillin; systemic
1.4
7.5
1301
11902
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
7.5
227
1537
L04AX01
ATC
azathioprine; systemic
2.2
7.5
75
354
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
80.4
7.4
8
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
13.4
7.4
12
9
SPAT1153
SPAT
Removal of sutures
1.4
7.3
434
3362
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.5
7.3
32
93
AAE05
NOMESCO Finland
Nasoendoscopic closure of cerebrospinal fluid fistula
+∞
7.3
7
*
B94.80
ICD-10 Finland
Late effects of bacterial meningitis
+∞
7.3
7
*
R40.2
ICD-10 Finland
Coma, unspecified
6.3
7.2
18
29
101
Kela drug reimbursment
Anterior pituitary hypofunction
5.8
7.2
19
33
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
7.2
105
576
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.6
7.2
50
197
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.2
7.1
72
341
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.8
7.1
42
151
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.8
7.1
108
603
N05BA04
ATC
oxazepam; oral
1.4
7.0
352
2641
R53
ICD-10 Finland
Malaise and fatigue
1.5
7.0
279
2006
G43.9
ICD-10 Finland
Migraine, unspecified
1.9
7.0
91
479
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
6.9
193
1281
M01AE02
ATC
naproxen; oral, rectal
1.3
6.9
865
7493
J01MA02
ATC
ciprofloxacin; systemic
1.3
6.9
550
4464
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
5.5
6.9
19
35
N03AX18
ATC
lacosamide; systemic
5.9
6.9
18
31
ZZC00
NOMESCO Finland
Graft of fascia
13.8
6.9
11
8
AAK00
NOMESCO Finland
Cranioplasty
13.8
6.9
11
8
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
4.1
6.9
25
62
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.1
6.9
25
62
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
6.9
104
576
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.1
6.9
69
328
N30.0
ICD-10 Finland
Acute cystitis
1.6
6.9
192
1273
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
2.3
6.8
61
275
J01FA10
ATC
azithromycin; systemic
1.3
6.8
915
8002
6BA02
NOMESCO Finland
NA
9.3
6.8
13
14
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
6.8
140
859
H47.1
ICD-10 Finland
Papilloedema, unspecified
5.7
6.8
18
32
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.8
6.8
40
144
Q07.0
ICD-10 Finland
Arnold-Chiari syndrome
16.8
6.7
10
6
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
4.3
6.7
23
54
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.1
6.7
24
59
79199
ICD-8 Finland
Headache
3.7
6.7
27
74
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
22.6
6.7
9
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.9
6.6
91
491
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
4.2
6.6
23
55
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
7.8
6.6
14
18
N03AE01
ATC
clonazepam; systemic
1.9
6.6
86
452
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
6.6
404
3140
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.2
6.6
62
287
WX704
NOMESCO Finland
Intubation
1.8
6.5
105
596
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.2
6.5
61
282
B01AA03
ATC
warfarin; systemic
1.5
6.4
223
1554
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.2
6.4
31
98
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
6.4
166
1080
N02AA05
ATC
oxycodone; systemic
1.6
6.3
176
1164
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.0
6.3
80
417
J01MA14
ATC
moxifloxacin; systemic
1.7
6.3
122
733
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
6.2
312
2338
G06.0
ICD-10 Finland
Intracranial abscess and granuloma
26.8
6.2
8
*
N02CA01
ATC
dihydroergotamine; nasal, systemic
7.0
6.2
14
20
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
6.2
286
2110
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.0
6.2
33
112
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.9
6.2
36
128
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.0
6.2
79
414
UDC00
NOMESCO Finland
Ear microscopy
1.8
6.1
102
587
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.2
6.1
58
269
WX872
NOMESCO Finland
Intensive care
2.1
6.1
66
326
N06AX16
ATC
venlafaxine; oral
1.5
6.1
205
1421
N28
ICPC
Limited function/disability (N)
3.7
6.1
24
65
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
6.0
138
872
N03AX11
ATC
topiramate; oral
2.5
6.0
43
172
L28
ICPC
Limited function/disability (L)
1.5
6.0
186
1264
R60.0
ICD-10 Finland
Localized oedema
1.6
6.0
136
856
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
5.2
6.0
17
33

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
362
395
11.04
309.86
2.0
1.3
mg/l
1044.9
492.3
13.64
350
372
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
270
137
22.73
307.65
2.1
1.7
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
341
347
11.71
306.48
1.8
1.2
mmol/l
3.3
3.7
6.33
320
325
(3044290) Cell count panel - Cerebral spinal fluid
314
319
11.55
281.83
2.0
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
174
74
25.73
245.82
1.3
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
166
64
28.27
242.99
1.9
2.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
214
161
14.82
231.11
1.7
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
170
80
23.19
230.64
1.3
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
292
353
9.56
229.33
1.9
1.4
e6/l
323.7
24.4
3.66
239
272
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
292
353
9.56
229.33
2.0
1.5
e6/l
827.0
697.7
0.11
243
286
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
158
114
15.00
173.99
2.1
1.2
mmol/l
3.5
1.9
6.50
153
108
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
160
176
9.82
133.57
1.3
1.0
au/ml
72.5
—
—
9
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
106
59
18.94
132.89
1.2
1.1
ng/l
539.1
37.7
—
59
9
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
99
49
21.23
130.75
1.4
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
149
159
10.07
127.13
1.1
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
98
55
18.71
122.30
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
142
163
9.32
114.55
1.6
1.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
83
41
21.10
109.55
1.3
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
82
42
20.34
106.53
1.3
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
75
37
21.04
98.96
1.3
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
70
32
22.65
95.28
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
69
38
18.79
86.62
1.3
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
69
41
17.41
83.53
1.2
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
72
48
15.54
82.20
1.1
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
54
22
25.21
76.66
2.1
1.2
%
54.4
38.0
—
47
6
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
77
76
10.51
69.09
2.0
1.1
%
51.4
61.7
—
41
7
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
46
18
26.15
66.16
1.3
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
46
20
23.53
63.62
1.3
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
82
101
8.43
62.23
1.3
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
40
16
25.50
56.99
1.1
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
47
28
17.17
56.65
1.2
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
290
1105
2.91
54.61
2.9
2.4
au/ml
38.1
23.6
0.81
12
73
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
271
1006
2.97
53.45
1.6
1.3
au/ml
53.2
41.9
—
10
47
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
52
47
11.34
49.42
1.7
1.2
%
25.6
22.6
—
35
5
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
89
158
5.85
48.20
1.6
1.7
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
96
188
5.32
46.77
5.4
6.4
mg/l
10.2
11.4
1.52
87
169
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
37
21
17.94
45.54
1.2
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
654
3866
2.04
44.64
4.7
4.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
37
22
17.12
44.53
1.2
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
28
12
23.65
38.69
1.4
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
28
15
18.92
35.26
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
50
79
6.47
30.39
1.2
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
65
139
4.80
28.60
1.3
1.1
mg/l
80.5
41.3
3.43
57
109
(3005719) IgG [Mass/volume] in Serum or Plasma
252
1205
2.25
28.57
3.8
2.7
g/l
10.0
10.5
1.31
241
1100
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
86
231
3.85
28.17
1.2
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
64
142
4.63
26.95
1.7
1.8
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
33
9
37.26
26.18
1.3
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
646
4402
1.70
24.84
2.5
2.1
u/l
148.3
245.0
2.33
622
4146
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
59
134
4.51
24.15
1.1
1.1
mg/l
480.0
270.2
2.13
51
112
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
386
2282
1.86
24.10
1.9
1.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
376
2231
1.85
23.11
2.1
2.2
s
29.2
29.7
0.83
366
2160
(3011412) CD3 cells [#/volume] in Blood
59
140
4.31
22.86
1.9
2.4
e9/l
1.6
1.2
1.55
27
80
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
119
444
2.79
22.81
1.3
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
57
133
4.38
22.56
1.1
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1017
7904
1.60
22.46
6.8
6.1
umol/l
10.3
11.3
2.39
966
7507
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
48
98
5.00
22.32
1.8
2.5
e9/l
0.2
0.2
0.01
40
84
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
51
111
4.69
22.00
1.2
1.1
u/l
1.2
1.1
0.99
25
61
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
40
70
5.81
21.98
1.2
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
33
49
6.83
21.26
1.5
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
48
103
4.75
21.07
1.8
2.5
e6/l
548.6
574.4
0.09
40
85
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
25
27
9.36
20.88
1.1
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
999
7846
1.56
20.24
7.5
5.9
e9/l
0.6
0.6
0.46
891
6830
(3006315) Basophils [#/volume] in Blood
1000
7872
1.56
19.93
7.5
5.9
e9/l
0.0
0.0
0.49
890
6855
(3013826) Glucose [Moles/volume] in Serum or Plasma
1098
8834
1.56
19.80
5.6
4.9
mmol/l
6.6
6.6
0.39
1041
8243
(3013115) Eosinophils [#/volume] in Blood
1026
8141
1.55
19.61
7.7
6.2
e9/l
0.2
0.2
0.79
917
7196
(3019198) Lymphocytes [#/volume] in Blood
1018
8093
1.54
19.07
7.5
5.9
e9/l
2.1
2.0
0.40
923
7178
(3032080) INR in Blood by Coagulation assay
777
5820
1.56
19.06
9.2
8.5
inr
1.2
1.2
0.23
227
1726
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
114
459
2.58
18.82
2.8
1.6
g/l
0.2
0.2
1.17
104
435
(3013247) Albumin in CSF/Albumin in Serum or Plasma
25
31
8.15
18.77
1.1
1.0
mg/g
12.1
8.1
0.94
25
31
(42870588) Differential panel, method unspecified - Blood
708
5209
1.57
18.72
7.6
5.9
—
—
—
0
0
(4027681)
48
114
4.29
18.60
1.2
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
965
7639
1.52
18.05
7.8
6.1
%
28.6
28.4
0.18
900
7163
(3006504) Eosinophils/100 leukocytes in Blood
936
7363
1.52
18.02
7.8
6.0
%
2.9
2.8
0.11
882
6891
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
929
7302
1.52
17.92
7.8
6.8
mmol/l
1.2
1.2
1.49
793
6189
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
23
8
29.06
17.42
1.0
1.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1106
9064
1.51
17.19
10.5
8.9
e9/l
4.2
4.1
1.31
993
7951
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
851
6616
1.51
16.98
7.1
6.1
mmol/l
1.2
1.2
2.20
785
6017
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
9
25.83
16.91
1.2
1.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
113
478
2.45
16.82
2.9
1.5
g/l
1.2
1.2
0.00
103
450
(3042936) Bacteria identified in Isolate by Culture
340
2134
1.72
16.80
1.9
2.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
933
7404
1.50
16.79
8.2
6.3
%
8.3
8.5
1.05
880
6971
(3022096) Basophils/100 leukocytes in Blood
905
7139
1.50
16.75
7.9
6.1
%
0.7
0.7
0.40
849
6699
(3018010) Neutrophils/100 leukocytes in Blood
945
7535
1.50
16.51
7.5
5.9
%
56.5
56.9
0.49
886
7093
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
21
7
30.30
16.11
1.0
1.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
49
132
3.78
16.05
1.9
2.2
%
46.8
41.0
—
10
14
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
644
4777
1.52
15.76
2.7
2.5
u/l
57.9
56.8
0.06
600
4432
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
43
108
4.05
15.52
1.6
2.0
%
10.5
12.8
0.71
22
52
(3024561) Albumin [Mass/volume] in Serum or Plasma
815
6370
1.48
15.35
5.6
4.9
g/l
35.5
36.0
1.34
766
5966
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
727
5568
1.49
15.08
3.4
3.4
ng/l
23.6
47.0
2.53
469
3611
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
45
120
3.81
14.97
2.0
2.5
e6/l
651.3
762.2
0.50
25
45
(3028026) IgM [Mass/volume] in Serum or Plasma
178
949
1.96
14.86
2.2
1.8
g/l
1.4
1.4
0.01
161
874
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
188
1022
1.93
14.82
1.9
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
261
1575
1.76
14.71
1.8
1.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
23
35
6.64
14.48
1.1
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
115
525
2.27
14.42
2.1
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
261
1586
1.75
14.34
1.8
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
40
102
3.98
14.16
1.8
2.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
65
229
2.90
13.92
1.3
1.3
mmol/l
76.4
66.1
0.81
50
192
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
21
31
6.84
13.58
1.4
1.3
—
—
—
0
0
(4062490)
50
157
3.24
13.04
1.5
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
73
285
2.62
12.88
1.7
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
25
47
5.37
12.77
2.0
2.9
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
17
21
8.16
12.76
1.4
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
99
447
2.28
12.76
1.9
1.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1351
11871
1.46
12.48
9.5
7.3
u/l
77.5
77.4
0.01
1302
11193
(3007853) Bacteria identified in Skin by Aerobe culture
280
1800
1.65
12.40
1.9
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1167
10004
1.42
12.20
5.9
4.2
e6/l
2959.0
2025.2
0.15
21
140
(3003396) Base excess in Arterial blood by calculation
257
1624
1.67
12.15
8.2
8.7
mmol/l
1.0
1.2
0.27
208
1263
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
17
23
7.45
11.84
1.2
2.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
111
550
2.08
11.36
2.4
2.1
ug/l
1.0
1.8
0.71
100
487
(3027135) IgG subclass 1 [Mass/volume] in Serum
47
156
3.06
11.22
1.6
1.3
g/l
5.7
6.8
1.67
35
111
(3028192) IgG subclass 2 [Mass/volume] in Serum
47
156
3.06
11.22
1.6
1.3
g/l
2.5
2.9
1.69
35
109
(3024139) IgG subclass 3 [Mass/volume] in Serum
47
156
3.06
11.22
1.6
1.3
g/l
0.3
0.4
1.03
35
109
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
253
1628
1.64
11.11
8.2
8.7
kpa
5.1
5.1
0.14
242
1557
(3027801) Oxygen [Partial pressure] in Arterial blood
253
1628
1.64
11.11
8.2
8.7
kpa
12.8
12.3
0.77
242
1559
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
97
461
2.16
11.06
1.4
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1300
11456
1.41
10.95
5.1
4.0
mm/h
11.7
11.2
0.73
1239
10669
(3033658) Prothrombin time (PT) actual/Normal
511
3854
1.44
10.70
4.4
3.9
%
92.6
91.7
0.35
501
3751
(3024980) IgG subclass 4 [Mass/volume] in Serum
64
258
2.53
10.63
1.9
1.7
g/l
0.7
0.9
0.64
49
198
(3016502) Oxygen saturation in Arterial blood
228
1450
1.65
10.47
8.6
9.2
%
96.2
95.6
0.61
219
1398
(3000060) B lymphocytes [#/volume] in Blood
21
41
5.17
10.31
1.4
2.1
e6/l
231.7
190.5
0.29
12
21
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
112
578
1.99
10.28
2.1
1.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
341
2392
1.52
10.26
3.8
3.7
mmol/l
0.8
0.8
0.29
323
2250
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
142
796
1.85
10.18
1.6
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
206
1286
1.67
10.15
7.9
7.9
mmol/l
8.1
9.1
1.59
200
1226
(3003458) Phosphate [Moles/volume] in Serum or Plasma
286
1946
1.55
9.87
6.6
6.0
mmol/l
1.0
1.0
1.04
274
1805
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
91
442
2.11
9.85
2.8
3.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
72
318
2.31
9.83
2.0
3.2
umol/l
30.8
34.4
1.03
63
275
(3026008) Bacteria identified in Urine by Culture
550
4262
1.41
9.75
3.5
2.9
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
45
159
2.87
9.67
1.6
1.5
mosm/kgh2o
285.9
281.4
0.70
36
119
(3037522) Nuclear Ab [Titer] in Serum
313
2185
1.52
9.59
1.4
1.3
titre
704.2
500.9
0.87
71
447
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72
323
2.28
9.49
5.8
6.1
iu/ml
477.4
403.8
0.14
12
44
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
382
2785
1.46
9.43
3.6
3.5
ng/l
195.1
481.0
2.46
262
2048
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
89
438
2.08
9.32
2.0
2.2
mg/l
10.4
11.3
0.55
84
405
(3032352) Blasts [#/volume] in Cerebral spinal fluid
13
17
7.69
9.28
1.2
2.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
9
15.65
9.03
1.8
1.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
228
1504
1.58
8.99
2.7
2.1
nmol/l
351.9
371.2
0.75
214
1382
(3002173) Hemoglobin [Mass/volume] in Arterial blood
209
1351
1.61
8.97
9.4
9.6
g/l
120.6
122.5
0.71
200
1302
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
13
7
18.68
8.93
1.5
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
76
358
2.17
8.92
1.6
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1200
10599
1.35
8.90
5.6
4.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
152
911
1.72
8.71
10.6
7.9
mmol/l
25.1
24.5
1.33
141
848
(3022217) INR in Platelet poor plasma by Coagulation assay
252
1725
1.53
8.42
20.0
22.3
inr
1.3
1.3
0.05
34
243
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
234
1576
1.55
8.41
3.5
4.4
u/l
227.4
246.5
1.56
220
1497
(40758558) Short blood count panel - Blood
503
3921
1.38
8.41
7.0
6.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
59
257
2.34
8.35
1.4
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
52
214
2.47
8.34
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
91
474
1.96
8.18
3.0
1.9
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
11
5
22.11
8.01
1.1
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
72
347
2.12
8.00
1.7
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
130
766
1.75
7.93
10.9
12.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
92
492
1.91
7.68
2.4
2.4
ug/l
664.1
460.0
0.25
83
463
(3047181) Lactate [Moles/volume] in Blood
87
458
1.94
7.61
9.2
8.1
mmol/l
1.3
1.3
0.02
75
401
(3019060) Gas panel - Arterial blood
151
939
1.66
7.56
8.1
5.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
336
2486
1.42
7.53
3.1
2.7
e6/l
1.2
1.3
0.07
186
1389
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
27
82
3.32
7.52
1.3
1.1
miu/ml
1785.8
1587.2
0.31
27
82
(3044640) Blood type and Crossmatch panel - Blood
591
4796
1.33
7.47
2.5
2.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
414
3181
1.38
7.45
1.6
1.5
g/l
2.3
2.4
0.28
276
1985
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
75
380
2.01
7.32
1.3
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
21
55
3.85
7.25
1.7
1.8
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
12
19
6.35
7.24
1.2
2.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
747
6292
1.30
7.16
2.6
2.3
nmol/l
76.9
75.9
0.48
676
5702
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
453
3565
1.35
6.96
1.7
1.8
mg/l
1.1
1.1
0.05
341
2682
(3011397) Hemoglobin [Presence] in Urine by Test strip
443
3479
1.35
6.89
4.3
3.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1218
10968
1.30
6.87
3.8
3.1
u/l
52.7
47.5
1.09
1164
10326
(3015171) Extractable nuclear Ab [Units/volume] in Serum
107
623
1.76
6.83
1.4
1.2
u/ml
0.3
1.1
—
9
50
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
139
873
1.64
6.72
1.5
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
80
428
1.91
6.71
1.5
1.2
u/ml
43.7
30.6
—
8
23
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
698
5869
1.30
6.65
2.0
1.9
pmol/l
98.9
95.8
0.76
362
3109
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
633
5267
1.30
6.50
3.7
3.3
u/l
33.0
32.4
0.14
601
5016
(3026782) Osmolality of Urine
376
2906
1.36
6.44
3.5
2.7
mosm/kgh2o
541.1
550.5
0.34
335
2482
(3002582) Erythrocytes [#/volume] in Urine
549
4488
1.31
6.41
4.3
3.1
e6/l
26.6
74.4
2.34
437
3436
(1761868) Lipid panel - Serum or Plasma
499
6071
0.76
6.36
2.5
2.7
—
—
—
0
0
(3039000) Anion gap in Blood
65
330
2.00
6.35
10.8
9.7
mmol/l
10.9
11.4
0.49
58
297
(3019150) Specific gravity of Urine by Refractometry
421
3320
1.34
6.31
4.7
3.7
kg/l
1.0
1.0
1.00
74
467
(3018572) Chloride [Moles/volume] in Blood
65
331
2.00
6.30
10.8
9.7
mmol/l
104.8
105.5
0.51
58
298
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
74
398
1.89
6.13
1.5
1.2
u/ml
5.3
10.2
0.53
17
63
(3019225) pH of Specimen
203
1419
1.48
6.11
4.4
4.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
633
5301
1.29
6.11
5.0
3.6
e6/l
44.1
99.3
2.33
460
3711
(3030467) Casts [#/volume] in Urine by Automated count
504
4101
1.31
6.04
4.0
3.0
e6/l
0.3
0.4
2.00
383
3070
(3000850) Epithelial cells [#/volume] in Urine
395
3108
1.34
5.98
3.5
2.5
e6/l
5.7
5.9
0.09
360
2741
(3025941) Bacteria identified in Stool by Culture
136
875
1.60
5.98
1.3
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
115
711
1.66
5.94
1.9
2.0
u/l
37.9
39.7
0.51
102
637
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
308
2340
1.38
5.84
3.4
2.9
e6/l
2.5
2.6
0.05
159
1245
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
58
292
2.02
5.83
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
58
292
2.02
5.83
1.3
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
191
1334
1.48
5.78
3.8
3.7
mmol/l
1.7
2.0
0.59
166
1069
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
831
7235
1.26
5.73
4.1
3.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
72
393
1.86
5.72
1.5
1.2
u/ml
5.9
2.6
—
10
38
(40761535) Cells panel - Urine sediment
175
1204
1.50
5.70
4.5
3.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1671
15864
1.39
5.70
19.7
13.1
mg/l
22.5
22.9
0.22
1418
12417
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
52
254
2.08
5.67
1.3
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
160
1092
1.51
5.43
3.0
3.0
e9/l
4.0
4.1
0.19
114
882
(3009445) Proteinase 3 Ab [Units/volume] in Serum
104
643
1.65
5.39
1.8
1.4
u/ml
18.8
9.4
—
5
20
(3035350) Ketones [Presence] in Urine by Test strip
866
7622
1.25
5.29
4.5
3.4
estimate
0.0
0.0
0.50
145
1432
(3015736) pH of Urine
687
5891
1.26
5.29
4.3
3.3
—
5.6
—
0
5
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
112
711
1.61
5.24
5.2
4.0
mmol/l
24.0
24.2
0.27
97
649
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
114
728
1.60
5.20
7.5
11.5
mmol/l
24.2
24.5
0.63
108
688
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
60
319
1.91
5.20
1.4
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
329
2570
1.34
5.19
1.9
1.7
nmol/l
1185.0
1188.6
0.02
262
1961
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
57
298
1.94
5.19
1.4
1.2
u/ml
1.0
5.3
—
5
24
(3005322) IgE [Units/volume] in Serum or Plasma
153
1048
1.50
5.11
1.4
1.3
u/ml
155.3
208.7
0.45
146
963
(3000991) Gas panel - Venous blood
173
1216
1.46
5.08
7.1
9.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
96
591
1.66
5.08
8.4
6.6
%
0.9
0.9
0.61
89
552
(40768804) Tissue Pathology biopsy report
711
6148
1.25
5.02
2.1
2.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
11
23
4.80
5.01
1.0
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
96
594
1.65
4.98
8.2
6.6
%
1.7
1.6
0.51
89
556
(3014576) Chloride [Moles/volume] in Serum or Plasma
243
1825
1.38
4.93
7.2
7.3
mmol/l
103.7
104.3
1.08
234
1783
(36304419) Bacteria [Presence] in Urine
486
4028
1.28
4.92
3.9
3.0
—
—
—
0
0
(44790049)
38
174
2.21
4.92
1.3
1.7
—
—
—
0
0
(44790047)
38
174
2.21
4.92
1.3
1.7
—
—
—
0
0
(44806118)
38
174
2.21
4.92
1.3
1.7
—
—
—
0
0
(44790048)
38
174
2.21
4.92
1.3
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
871
7719
1.23
4.85
4.5
3.5
estimate
0.0
0.0
1.32
148
1392
(3023520) Reticulocytes [#/volume] in Blood
160
1120
1.47
4.81
2.1
2.8
e9/l
67.2
71.6
0.79
123
854
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
50
257
1.97
4.80
1.9
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
45
223
2.04
4.78
1.4
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
863
7652
1.23
4.75
6.0
4.7
estimate
0.0
0.0
0.50
152
1460
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
444
3658
1.28
4.69
2.6
2.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
30
127
2.38
4.65
1.1
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
26
103
2.54
4.63
1.7
2.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
198
1460
1.40
4.49
2.5
2.4
u/l
31.8
71.7
0.65
173
1244
(3027945) Reticulocytes/100 erythrocytes in Blood
207
1539
1.39
4.47
2.3
2.7
%
1.7
1.8
0.39
186
1388
(3024891) Influenza virus A+B Ag [Presence] in Specimen
76
456
1.69
4.46
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
106
695
1.56
4.37
5.0
3.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
189
1390
1.40
4.36
2.4
2.3
g/l
0.2
0.2
0.34
179
1308
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
75
452
1.69
4.34
3.1
3.2
u/ml
0.3
0.4
0.19
43
249
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
15
45
3.35
4.32
1.3
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
22
4.56
4.30
1.1
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
34
159
2.16
4.22
3.3
4.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
59
335
1.78
4.22
1.4
1.2
u/ml
21.0
44.4
1.08
12
31
(3015377) Calcium [Moles/volume] in Serum or Plasma
581
4998
1.23
4.14
3.6
3.4
mmol/l
2.3
2.4
0.82
508
4420
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
29
128
2.28
4.13
1.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
29
128
2.28
4.13
1.6
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
29
128
2.28
4.13
1.6
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
94
608
1.57
4.13
4.8
4.0
mmol/l
24.7
24.9
0.27
87
570
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
136
952
1.46
4.12
4.9
3.6
kpa
5.2
5.2
0.02
128
896
(46235355) HIV 1 and 2 tests - Meaningful Use set
392
3237
1.26
4.02
2.1
1.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
27
117
2.33
4.01
1.3
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
20
75
2.68
3.99
1.7
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
75
2.68
3.99
1.7
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
75
2.68
3.99
1.6
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
75
2.68
3.99
1.7
1.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1300
12129
1.22
3.97
4.4
3.9
pmol/l
14.7
14.7
0.03
1196
11150
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
36
177
2.05
3.95
1.5
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
27
118
2.31
3.94
1.3
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
34
164
2.09
3.92
2.4
6.8
mmol/l
7.8
7.0
0.21
22
137
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
103
689
1.52
3.91
2.8
2.5
%
1.1
1.3
0.74
103
684
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
677
5950
1.21
3.85
4.7
3.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
129
907
1.45
3.84
4.9
3.7
mmol/l
1.3
1.7
0.66
99
668
(3000570) Elastase.pancreatic [Mass/mass] in Stool
71
437
1.65
3.83
1.4
1.5
ug/g
266.0
289.4
0.48
41
244
(3035637) Corticotropin [Mass/volume] in Plasma
38
193
1.99
3.83
1.2
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
38
194
1.98
3.78
1.5
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
503
4300
1.23
3.75
4.7
3.9
ph
7.4
7.4
1.33
101
832
(3025468) Yersinia sp identified in Specimen by Organism specific culture
35
174
2.03
3.75
1.5
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
35
174
2.03
3.75
1.5
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
35
174
2.03
3.75
1.5
1.5
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
10
25
4.01
3.70
1.4
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
10
25
4.01
3.70
1.4
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
10
25
4.01
3.70
1.4
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
35
175
2.02
3.69
1.5
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
250
1973
1.31
3.65
1.7
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
227
1768
1.32
3.65
2.7
2.7
umol/l
6.7
7.9
0.58
191
1537
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
49
276
1.80
3.64
1.2
1.1
—
10.1
—
0
18
(3000494) Fungus identified in Specimen by Culture
234
1832
1.32
3.62
1.6
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
134
960
1.42
3.62
3.2
3.3
pmol/l
4.4
4.6
0.57
114
844
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
33
163
2.04
3.60
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
35
177
1.99
3.59
1.5
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
46
3.06
3.53
3.4
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
46
3.06
3.53
3.4
2.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
24
105
2.30
3.52
1.1
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
155
1145
1.38
3.52
2.7
2.7
g/l
66.6
66.9
0.12
143
1057
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
370
3080
1.25
3.51
1.6
1.7
pmol/l
65361890.3
33372384.5
0.28
332
2589
(3003327) Ova and parasites identified in Stool by Light microscopy
82
535
1.56
3.51
1.8
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
23
99
2.34
3.50
1.3
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
131
942
1.42
3.48
5.1
3.7
ph
7.4
7.4
0.02
14
117
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
56
333
1.70
3.47
5.1
4.0
%
55.7
57.3
0.36
56
333
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
273
2195
1.28
3.46
1.7
1.8
%
1.5
1.4
0.17
241
1951
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
90
603
1.52
3.43
1.5
2.0
g/l
1.6
1.5
0.15
80
529
(3004616) Nuclear Ab [Presence] in Serum
33
167
1.99
3.39
1.5
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
454
3881
1.22
3.35
2.9
3.0
ng/l
1254.3
1226.6
0.03
385
3278
(3052851) Hemolysis interference index of Serum or Plasma
66
414
1.61
3.35
3.1
3.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
49
284
1.74
3.33
1.7
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
54
322
1.70
3.32
4.7
3.7
e9/l
3.8
4.2
0.55
54
322
(3022621) pH of Urine by Test strip
134
977
1.40
3.30
2.8
2.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
169
1282
1.35
3.26
4.4
4.3
%
0.9
0.9
0.05
54
366
(3021960) Folate [Moles/volume] in Serum or Plasma
390
3291
1.23
3.26
1.5
1.5
nmol/l
21.9
20.8
0.72
332
2832
(3004119) Hemoglobin [Mass/volume] in Venous blood
123
886
1.41
3.25
2.9
3.1
g/l
125.9
130.4
1.57
123
866
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
13
43
3.04
3.25
2.1
1.9
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
21
90
2.35
3.24
1.1
1.0
ng/l
229.6
291.7
0.46
12
55
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
16
60
2.68
3.22
1.8
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
16
60
2.68
3.22
1.8
2.0
—
—
—
0
0
(3020891) Body temperature
84
563
1.51
3.21
7.3
4.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
33
3.35
3.19
1.1
1.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
21
91
2.32
3.17
1.1
1.0
ng/l
697.4
739.9
0.16
13
55
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
21
91
2.32
3.17
1.1
1.0
ng/l
33.9
42.9
—
10
53
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
16
61
2.64
3.13
1.8
2.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
470
4066
1.21
3.05
5.1
3.8
estimate
0.0
0.0
1.28
139
1421
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
7
12
5.85
3.02
1.3
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
21
4.30
2.99
1.1
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
5
10.02
2.98
1.6
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1664
16067
1.25
2.97
20.5
14.7
mmol/l
139.5
139.6
2.11
1639
15664
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1170
10946
1.17
2.96
3.3
3.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
423
3633
1.21
2.95
5.9
4.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
460
3983
1.20
2.95
2.8
2.6
umol/l
1449.8
5154.6
2.31
412
3506
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
432
3723
1.21
2.91
2.3
2.1
mg/l
3.0
2.9
0.06
377
3179
(3032057) Clostridioides difficile [Presence] in Stool
10
30
3.34
2.90
2.4
2.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
248
2015
1.26
2.90
2.6
2.5
ug/g
132.4
120.6
0.29
202
1612
(3004789) Transferrin [Mass/volume] in Serum or Plasma
256
2089
1.26
2.89
2.8
2.4
g/l
2.3
2.3
0.10
245
1940
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
9
22
4.10
2.88
2.3
2.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
9
22
4.10
2.88
1.2
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
67
439
1.54
2.87
6.1
4.0
mmol/l
3.9
3.9
0.12
62
409
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
9
6.68
2.87
1.8
5.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
18
77
2.35
2.82
1.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
18
77
2.35
2.82
1.3
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
53
331
1.62
2.79
1.7
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
51
316
1.63
2.77
2.1
2.3
g/l
131.2
130.1
0.08
32
239
(3009466) Valproate [Moles/volume] in Serum or Plasma
43
255
1.70
2.75
4.5
5.5
umol/l
358.1
373.3
0.31
36
224
(3022229) Phosphate [Moles/volume] in Urine
5
6
8.35
2.75
3.2
2.5
mmol/l
8.5
22.2
—
5
6
(3021589) Normoblasts [#/volume] in Blood
764
6941
1.17
2.74
11.0
9.2
e9/l
0.0
0.0
0.66
626
5705
(3004809) Band form neutrophils/100 leukocytes in Blood
39
227
1.73
2.67
3.9
3.5
%
0.7
1.5
1.39
33
187
(3001122) Ferritin [Mass/volume] in Serum or Plasma
762
6935
1.16
2.65
3.0
2.8
ug/l
112.3
119.4
0.45
709
6454
(3026389) Candida sp identified in Specimen by Organism specific culture
33
184
1.81
2.61
1.2
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
50
314
1.61
2.59
6.1
3.4
—
—
—
0
0
(4035726)
163
1277
1.30
2.56
1.4
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
5
7
7.15
2.55
1.0
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1664
16121
1.23
2.53
20.5
14.8
mmol/l
4.0
4.0
0.23
1635
15688
(3024928) Oxygen saturation in Venous blood
50
316
1.60
2.53
2.2
3.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
218
1775
1.26
2.52
7.8
6.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
143
1104
1.32
2.50
4.1
3.9
ng/l
78.9
83.4
0.35
125
975
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
68
463
1.49
2.48
2.1
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
51
326
1.58
2.47
8.5
4.0
mmol/l
2.7
2.5
0.10
27
216
(3002179) Metamyelocytes/100 leukocytes in Blood
150
1169
1.31
2.46
4.1
4.1
%
0.6
0.6
0.09
40
269
(40768797) Stomach Pathology biopsy report
256
2130
1.23
2.45
1.2
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
36
211
1.72
2.43
1.6
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
87
625
1.41
2.41
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
155
1220
1.29
2.37
4.4
4.4
%
0.2
0.1
0.17
52
336
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
30
168
1.80
2.37
1.8
2.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
154
1212
1.29
2.36
2.3
2.3
ug/l
6.0
7.2
0.49
132
1084
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1539
14834
1.18
2.31
15.3
11.8
ml/min/173m2
85.8
84.6
1.32
1332
12197
(3029396) Erythrocyte agglutination [Presence] in Blood
10
35
2.87
2.30
1.6
3.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
48
309
1.57
2.28
1.6
1.4
u/ml
99.9
116.7
—
7
64
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
41
2.69
2.27
1.5
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
53
2.46
2.27
1.5
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
24
127
1.90
2.26
1.2
1.5
promille
0.7
1.3
1.52
19
102
(3022948) Iron [Moles/volume] in Serum or Plasma
270
2279
1.21
2.25
2.8
2.5
umol/l
12.9
13.6
0.66
259
2112
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
87
635
1.39
2.22
3.6
3.6
%
50.2
49.3
0.12
87
626
(3045414) Leukocytes [Presence] in Urine
92
678
1.37
2.22
1.8
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
204
1678
1.24
2.18
1.6
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
42
2.63
2.18
1.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
28
158
1.78
2.17
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
76
544
1.41
2.17
1.3
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
233
1945
1.22
2.17
2.9
2.5
%
22.5
23.4
0.37
202
1673
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
307
2633
1.20
2.17
1.3
1.3
u/ml
6.8
11.4
1.01
116
1055
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
75
536
1.41
2.16
1.3
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
51
338
1.52
2.15
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
85
622
1.38
2.14
1.1
1.1
—
—
—
0
0
(3010421) pH of Blood
58
396
1.48
2.13
7.9
3.8
ph
7.4
7.4
0.81
47
322
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
197
1.69
2.12
1.5
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
139
1098
1.29
2.10
2.8
2.9
ng/l
166.3
192.4
0.36
120
999
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
320
2766
1.19
2.07
1.4
1.3
iu/ml
24.8
29.2
0.33
104
873
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
50
333
1.51
2.07
1.3
1.6
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
10
5.01
2.07
1.8
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
15
69
2.18
2.04
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
141
1120
1.28
2.04
1.2
1.2
iu/ml
92.8
145.8
1.05
51
436
(3025159) Blasts/100 leukocytes in Blood
144
1148
1.27
2.03
4.4
4.4
%
0.0
0.7
0.91
47
283
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
58
401
1.46
2.01
1.3
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
14
63
2.23
2.01
1.1
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
72
519
1.40
2.00
1.5
1.6
iu/ml
0.1
0.1
0.10
19
86
(3003740) Influenza virus B Ag [Presence] in Specimen
46
304
1.53
1.98
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
46
304
1.53
1.98
1.2
1.1
—
—
—
0
0
(4146454)
26
148
1.77
1.98
3.0
2.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
215
1799
1.22
1.97
4.7
4.2
%
32.0
31.6
0.15
141
1251
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
512
1.40
1.97
2.9
2.4
g/l
3.5
3.7
0.80
44
380
(3017446) Testosterone [Moles/volume] in Serum or Plasma
158
1279
1.26
1.97
2.4
2.3
nmol/l
12.6
13.1
0.32
140
1143
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
65
462
1.42
1.96
1.2
1.2
—
—
—
0
0
(3013512) EKG study
466
4169
1.15
1.96
3.9
3.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
513
1.40
1.95
2.9
2.4
g/l
7.1
7.3
0.38
48
398
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
513
1.40
1.95
2.9
2.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
12
51
2.36
1.95
2.3
1.9
ug/l
95.5
61.4
0.45
12
51
(3009214) Lutropin [Units/volume] in Serum or Plasma
72
522
1.39
1.94
1.8
1.4
u/l
10.2
8.8
0.40
62
427
(3051611) Lipemic interference index of Serum or Plasma
24
135
1.79
1.91
3.5
3.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
158
1284
1.25
1.91
1.4
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
51
348
1.48
1.91
1.7
1.6
e6/l
12218.3
12127.0
0.01
44
261
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
42
275
1.54
1.90
1.3
1.2
u/ml
2.5
3.0
0.16
17
85
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
62
440
1.42
1.89
3.2
2.6
g/l
1.2
0.9
0.21
54
396
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
22
121
1.83
1.88
1.1
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
41
269
1.54
1.85
2.9
3.9
u/ml
126.3
1421.1
0.79
36
258
(3044009) aPTT.lupus sensitive (LA screen)
6
17
3.54
1.83
1.5
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
24
137
1.76
1.83
3.3
3.5
%
55.8
54.9
0.08
17
97
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
75
555
1.37
1.81
1.3
1.3
miu/ml
163.1
222.0
1.01
36
267
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1474
14240
1.15
1.81
5.6
5.3
mmol/mol
39.5
39.4
0.22
1377
13282
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
35
2.58
1.80
1.6
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
51
353
1.46
1.79
1.3
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
20
109
1.84
1.77
2.5
2.9
%
38.7
43.1
—
6
31
(3014765) Yersinia sp identified in Stool by Organism specific culture
64
464
1.39
1.75
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
72
533
1.36
1.74
4.6
3.3
g/l
0.2
0.2
0.18
31
234
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
356
3149
1.16
1.74
1.7
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
32
201
1.60
1.74
2.3
2.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
21
117
1.80
1.74
1.9
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
40
265
1.52
1.74
1.3
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
408
3647
1.15
1.73
1.3
1.3
u/ml
2.3
1.7
0.27
107
992
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1491
14429
1.14
1.73
5.2
4.6
mu/l
1.8
2.0
1.13
1385
13332
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
155
1.69
1.72
1.2
1.2
u/l
60.4
55.0
0.22
20
111
(3022145) Colonoscopy Study observation
205
1733
1.20
1.72
1.6
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
300
2622
1.17
1.72
1.7
1.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
61
2.14
1.71
2.3
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
476
1.38
1.69
2.6
2.4
g/l
10.1
10.4
0.14
52
412
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
20
111
1.81
1.68
1.1
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
64
468
1.38
1.68
1.2
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
42
2.39
1.67
1.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
55
2.19
1.67
1.2
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
85
651
1.32
1.66
1.9
1.6
mu/l
272.8
298.5
0.57
78
593
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
30
188
1.60
1.66
1.2
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
23
134
1.72
1.66
2.7
2.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
62
2.10
1.65
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
62
2.10
1.65
1.3
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
25
2.81
1.65
1.9
1.7
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
25
2.81
1.65
1.3
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
28
173
1.63
1.64
1.9
2.3
mg/l
19.9
25.6
—
8
50
(3023419) Bacteria identified in Sputum by Culture
30
189
1.60
1.63
3.3
3.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
40
270
1.49
1.61
1.3
1.2
u/ml
8.6
5.2
0.50
17
109
(3036489) Thrombin time
80
611
1.32
1.60
2.1
2.2
s
20.5
21.2
0.96
66
535
(3051651) Icteric interference index of Serum or Plasma
16
84
1.91
1.59
4.1
4.1
—
—
—
0
0
(4034850)
67
499
1.35
1.59
7.3
9.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
168
1408
1.21
1.56
3.9
4.2
ug/l
10.8
19.7
0.44
125
1144
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1725
16905
1.18
1.55
13.0
9.9
u/l
28.0
27.2
0.74
1685
16382
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
484
1.35
1.55
2.8
2.4
g/l
2.9
3.1
0.55
46
387
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
38
257
1.49
1.53
1.1
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
298
2634
1.15
1.49
3.4
3.0
mmol/l
2.4
2.4
0.11
266
2321
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
57
419
1.37
1.48
2.9
3.5
mg/l
31.3
39.3
0.46
45
327
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
68
516
1.33
1.45
4.0
3.6
u/ml
490.7
2804.4
0.62
58
438
(3014051) Protein [Presence] in Urine by Test strip
47
338
1.40
1.40
2.3
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
219
1901
1.17
1.39
1.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
210
1817
1.17
1.39
1.4
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
60
2.01
1.38
2.1
2.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
41
2.20
1.37
1.7
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
17
2.95
1.36
1.4
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
17
2.95
1.36
1.4
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
15
82
1.84
1.35
1.3
1.3
nmol/l
125.1
145.1
1.14
15
82
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
69
531
1.31
1.35
2.1
2.4
%
92.7
93.0
0.03
64
495
(36660697) Celiac disease serology panel - Serum
151
1275
1.20
1.33
1.2
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
56
419
1.35
1.33
2.9
3.5
mg/l
44.1
65.5
0.66
44
326
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
53
395
1.35
1.29
2.5
2.5
g/l
0.0
0.0
0.29
48
368
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
18
2.78
1.28
1.8
2.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
13
69
1.89
1.28
2.2
1.5
iu/ml
430361.7
1290600.0
—
6
5
(3000330) Specific gravity of Urine by Test strip
89
714
1.26
1.28
3.9
3.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
55
2.01
1.27
1.2
2.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
34
236
1.45
1.25
1.2
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
36
253
1.43
1.24
1.4
1.4
u/l
20.9
23.6
0.27
30
206
(3034274) Bile acid [Moles/volume] in Serum --fasting
28
187
1.50
1.24
2.6
2.2
umol/l
9.0
6.0
0.63
20
133
(3025130) Human papilloma virus identified in Specimen
32
220
1.46
1.23
2.2
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
145
1230
1.19
1.23
3.2
2.5
ml/min/173m2
64.1
69.8
0.97
55
482
(40760888) Immunoglobulin light chains.free panel - Serum
43
313
1.38
1.22
2.8
3.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
19
2.63
1.21
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
28
188
1.50
1.21
2.4
3.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
27
180
1.51
1.21
1.5
1.7
%
53.0
57.9
0.23
21
122
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
17
101
1.69
1.19
2.0
1.5
u/l
8.3
8.3
0.00
12
50
(3007566) Smooth muscle Ab [Titer] in Serum
58
445
1.31
1.19
1.1
1.3
titre
90.0
93.0
—
5
40
(3009508) Creatinine [Moles/volume] in Urine
499
4620
1.11
1.18
3.5
3.2
mmol/l
7.8
7.8
0.04
424
3929
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
26
2.31
1.18
1.0
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
41
299
1.38
1.16
3.1
2.5
%
16.6
16.3
0.15
21
150
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
174
1509
1.17
1.15
3.6
3.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
18
110
1.64
1.15
1.4
1.1
ratio
1.1
1.0
—
9
45
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
19
118
1.62
1.14
1.4
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
53
404
1.32
1.14
2.1
2.4
g/l
36.9
38.0
0.52
44
358
(3021901) Oxygen saturation in Capillary blood
36
258
1.40
1.13
4.6
2.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
159
1834
0.85
1.12
1.4
1.3
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
13
73
1.79
1.10
34.3
27.6
ug/l
101.6
126.7
1.24
13
57
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
45
337
1.34
1.10
1.4
1.3
u/ml
253.9
254.0
0.00
31
210
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
202
1781
1.15
1.08
1.6
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
462
4284
1.10
1.06
4.1
3.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
113
953
1.20
1.05
3.0
2.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
19
289
0.65
1.05
1.7
1.5
—
—
—
0
0
(4010399)
125
1065
1.19
1.04
1.4
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
99
828
1.21
1.01
1.6
1.4
iu/l
25.3
26.7
0.16
88
704
(3012441) Differential panel - Pleural fluid
19
123
1.55
0.99
1.5
1.4
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
13
76
1.71
0.99
2.2
2.2
ug/l
1.8
2.0
—
8
67
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
61
1.81
0.98
1.3
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
11
61
1.81
0.98
1.2
1.2
—
—
—
0
0
(44806071)
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
30
0.00
0.97
0.0
2.2
—
—
—
0
0
(4015189)
7
36
1.95
0.97
3.6
3.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
35
258
1.36
0.97
1.2
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
19
124
1.54
0.96
1.2
1.3
e6/l
68052.3
130677.3
0.41
14
71
(3035320) C reactive protein [Mass/volume] in Body fluid
17
108
1.58
0.96
2.1
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
237
2133
1.13
0.95
2.3
2.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
31
225
1.38
0.94
1.6
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
35
260
1.35
0.93
1.2
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
79
653
1.22
0.93
2.2
2.2
u/l
1286.7
4285.2
1.91
29
252
(40758292) HTLV I+II Ab panel - Serum
6
28
2.15
0.91
1.3
1.4
—
—
—
0
0
(4198724)
13
78
1.67
0.91
1.8
1.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
19
127
1.50
0.88
1.4
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
24
335
0.71
0.88
1.9
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
18
119
1.52
0.88
1.9
1.9
%
10.7
11.2
0.23
18
119
(3025018) Bordetella pertussis Ab [Titer] in Serum
15
95
1.58
0.87
1.1
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
74
613
1.22
0.86
1.7
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
64
1.72
0.86
1.0
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
11
64
1.72
0.86
5.6
2.1
ug/l
0.9
1.4
0.74
11
58
(3016650) Hepatitis A virus Ab [Presence] in Serum
37
282
1.32
0.85
1.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
13
80
1.63
0.84
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
35
265
1.33
0.84
1.4
1.7
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
31
1.94
0.84
35.0
7.4
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
6
32
1.88
0.81
2.7
3.8
ng/l
142.8
77.3
—
6
19
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
73
1.65
0.81
2.8
3.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
214
1936
1.12
0.81
2.2
2.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
106
914
1.17
0.81
2.4
1.8
—
—
—
0
0
(4094501)
54
436
1.25
0.81
1.1
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
135
1188
1.15
0.79
5.6
3.7
mmol/l
1.2
1.2
2.51
125
1030
(3032773) Endomysium IgG Ab [Titer] in Serum
9
150
0.60
0.78
1.0
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
40
313
1.28
0.78
3.0
2.8
mmol/l
1.5
1.6
0.21
40
303
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
82
1.59
0.78
1.8
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
82
1.59
0.78
1.8
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
7
123
0.57
0.78
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
53
1.70
0.75
1.1
1.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
18
124
1.46
0.75
1.2
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
24
2.09
0.74
9.2
5.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
19
133
1.43
0.73
2.4
2.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
35
272
1.29
0.73
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
57
1.58
0.71
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
35
274
1.28
0.69
1.1
1.1
iu/ml
118.4
123.4
—
8
69
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
58
1.55
0.69
2.7
4.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
46
373
1.24
0.69
6.0
2.9
mmol/l
24.8
24.9
0.04
40
331
(3052592) Norovirus Ag [Presence] in Stool
5
27
1.85
0.68
1.6
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
10
61
1.64
0.68
3.7
2.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
42
1.67
0.68
1.6
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
149
1656
0.89
0.68
1.7
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
85
735
1.16
0.66
2.6
2.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
28
1.79
0.66
2.0
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
71
605
1.18
0.66
1.5
2.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1686
16656
1.09
0.65
17.3
12.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
35
277
1.27
0.65
1.1
1.1
—
—
—
0
0
(4211845)
11
70
1.57
0.65
3.5
2.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
16
112
1.43
0.63
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
100
1133
0.88
0.63
1.3
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
200
0.70
0.63
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
440
4176
1.07
0.60
3.7
3.3
mg/l
810.2
342.4
0.80
285
2669
(3037756) Immunofixation for Serum or Plasma
36
290
1.25
0.59
1.9
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
52
1.54
0.59
1.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
52
1.54
0.59
2.3
1.4
ug/l
10.6
8.8
—
8
52
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
58
681
0.85
0.59
1.9
1.7
mg/l
6.4
4.7
0.24
43
478
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
14
97
1.45
0.59
1.1
1.5
u/l
5.2
6.6
—
9
77
(3000492) Spirometry study
177
1620
1.10
0.58
1.5
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
228
1.28
0.58
1.2
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
1104
10777
1.06
0.57
3.7
3.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
35
1.72
0.57
34.8
7.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
15
106
1.42
0.57
1.0
1.1
iu/ml
8.6
10.7
—
5
26
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
62
531
1.17
0.56
1.5
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
149
0.67
0.56
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
115
1.39
0.56
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
115
1.39
0.56
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
115
1.39
0.56
1.1
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
73
1.51
0.56
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
116
1.38
0.54
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
116
1.38
0.54
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
116
1.38
0.54
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
38
1.58
0.54
2.0
2.1
umol/l
23.0
17.3
—
6
38
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
99
1.42
0.54
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
18
134
1.35
0.53
1.6
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
98
874
1.13
0.53
1.3
1.4
—
—
—
0
0
(4024509)
16
117
1.37
0.52
2.0
1.4
—
—
—
0
0
(4306422)
33
269
1.23
0.51
1.2
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
44
370
1.19
0.51
2.2
2.5
g/l
0.0
0.0
0.00
39
344
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
33
271
1.22
0.48
6.8
2.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
20
154
1.30
0.48
1.1
1.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
55
475
1.16
0.48
2.7
2.8
g/l
3.9
3.6
0.64
55
451
(3051593) INR in Capillary blood by Coagulation assay
7
47
1.49
0.47
7.9
12.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
119
0.67
0.45
1.3
1.4
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
11
77
1.43
0.45
38.6
34.5
ug/l
6.5
7.5
1.36
11
68
(40765089) Chromosome analysis panel - Blood by G-banded
8
57
1.40
0.42
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
140
1.29
0.42
4.2
3.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
176
1.25
0.41
2.6
2.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
33
1.52
0.41
5.6
1.6
mmol/l
1.2
1.2
—
5
33
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
14
105
1.34
0.41
1.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
11
79
1.39
0.40
2.2
1.7
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
34
1.47
0.40
2.4
1.9
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
60
1.33
0.40
1.4
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
97
1.34
0.39
1.8
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
455
4385
1.05
0.38
4.3
4.0
mg/mmol
17.7
8.8
1.52
295
2791
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
126
1165
1.09
0.38
2.5
1.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
31
261
1.19
0.38
1.2
1.0
u/ml
2.2
2.4
—
10
123
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
272
2589
1.06
0.37
1.5
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
17
134
1.27
0.37
1.3
1.4
nmol/l
1.2
1.5
0.74
17
120
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
40
347
1.16
0.35
1.9
2.2
nmol/l
0.8
0.9
0.06
33
298
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
28
236
1.19
0.35
1.5
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
45
395
1.14
0.35
1.6
2.0
iu/l
2.8
5.0
2.34
16
139
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
6
44
1.36
0.34
1.2
1.2
pmol/l
331.8
292.1
—
6
28
(3038515) Glucose [Moles/volume] in Venous blood
34
293
1.16
0.33
3.1
2.9
mmol/l
8.0
7.3
0.48
34
286
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
31
265
1.17
0.33
1.5
1.5
nmol/l
0.3
0.3
0.01
22
213
(3039443) Prostate specific Ag panel - Serum or Plasma
29
339
0.85
0.33
1.9
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
41
359
1.14
0.33
4.5
4.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
72
791
0.91
0.33
1.6
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
34
392
0.86
0.33
1.6
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
46
407
1.13
0.32
2.0
1.9
pmol/l
196.6
202.7
0.15
46
383
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
74
1.35
0.32
1.1
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
101
1.29
0.31
1.4
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
193
1.19
0.30
1.2
1.3
nmol/l
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
19
229
0.83
0.30
1.5
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
75
1.33
0.30
1.1
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
75
1.33
0.30
1.1
1.9
—
—
—
0
0
(3024471) HLA-A [Type]
7
55
1.27
0.30
1.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
102
1.28
0.30
1.2
1.9
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
56
1.25
0.29
1.1
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
436
4492
0.96
0.29
1.4
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
56
506
1.11
0.29
2.5
2.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
94
872
1.08
0.29
1.0
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1372
13854
0.97
0.28
22.4
16.4
g/l
332.9
333.0
0.11
1363
13755
(3015183) Erythrocyte sedimentation rate
12
95
1.26
0.26
1.2
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
10
77
1.30
0.26
1.1
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
74
0.67
0.26
1.0
1.1
iu/ml
110.2
207.7
—
5
74
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
70
646
1.09
0.25
1.1
1.1
—
0.9
—
0
10
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
15
123
1.22
0.25
1.1
1.3
u/ml
0.2
0.6
—
10
55
(4268621)
21
180
1.17
0.23
2.2
2.3
—
—
—
0
0
(4281824)
18
152
1.19
0.23
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
17
143
1.19
0.23
2.8
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
76
708
1.08
0.23
1.5
2.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
40
361
1.11
0.23
2.3
2.4
ug/min
48.0
115.9
1.77
20
227
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
97
1.24
0.22
1.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
93
0.75
0.22
2.6
1.9
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
5
41
1.22
0.22
1.4
1.3
mu/l
92.0
67.3
—
5
32
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
19
220
0.86
0.21
1.1
1.0
u/ml
0.1
0.5
—
5
54
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(4038314)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
11.8
—
0
11
(3041672) Baker's yeast Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
5
43
1.16
0.21
1.2
1.1
%
37.5
31.0
—
5
37
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.3
—
29.0
—
0
5
(3018001) Oat IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.3
—
0
5
(40761536) Microorganisms panel - Urine sediment
128
1342
0.95
0.20
5.4
3.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
117
1.20
0.20
1.7
1.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1484
14934
0.97
0.20
18.6
13.8
%
39.7
40.3
1.58
1119
11256
(3023511) Choriogonadotropin [Units/volume] in Urine
39
355
1.10
0.20
1.3
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
358
3670
0.97
0.20
3.9
3.9
%
20.9
21.2
0.13
156
1580
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1526
15162
1.03
0.19
4.4
4.2
mmol/l
5.9
5.9
0.36
1405
13929
(40768793) Breast Pathology biopsy report
38
346
1.10
0.19
1.2
1.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
17
146
1.17
0.19
3.1
4.5
u/ml
14.9
90.9
—
7
42
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
52
1.15
0.19
2.2
2.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
37
337
1.10
0.19
2.0
2.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
60
1.17
0.17
5.4
4.8
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
60
1.17
0.17
1.0
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
7
61
1.15
0.17
1.4
1.1
g/l
0.3
0.3
—
7
50
(3027456) Digoxin [Moles/volume] in Serum or Plasma
27
243
1.11
0.17
3.1
3.1
nmol/l
0.7
0.9
0.58
19
195
(3014133) Dog dander IgE Ab [Units/volume] in Serum
23
257
0.89
0.17
1.0
1.0
u/ml
5.7
3.0
0.39
11
94
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
24
215
1.12
0.16
1.3
1.3
nmol/l
0.5
0.6
0.58
24
205
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
8
69
1.16
0.16
2.0
3.3
mg/l
11.3
8.4
—
8
62
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
27
298
0.90
0.16
1.6
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
18
158
1.14
0.16
1.1
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
8
72
1.11
0.16
1.5
1.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
79
0.76
0.15
1.3
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
22
197
1.12
0.15
1.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
81
1.11
0.15
1.4
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
79
752
1.05
0.14
1.5
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
55
518
1.06
0.14
2.5
3.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
96
0.83
0.13
1.4
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
103
1.17
0.13
1.1
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
44
412
1.07
0.13
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
44
412
1.07
0.13
1.3
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
21
232
0.90
0.13
1.0
1.1
u/ml
4.2
5.0
—
9
92
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
9
107
0.84
0.13
1.2
1.4
—
1.5
—
0
5
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
44
413
1.07
0.13
1.3
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
29
314
0.92
0.13
1.1
1.1
u/ml
15.7
5.3
1.06
19
166
(3013139) Helicobacter pylori Ag [Presence] in Stool
106
1022
1.04
0.12
1.2
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
44
414
1.06
0.12
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
263
2683
0.98
0.12
2.9
2.8
ug/l
0.6
0.7
1.22
169
1628
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
12
136
0.88
0.11
1.4
1.4
mmol/l
10.6
12.7
—
5
33
(40768795) Lymph node Pathology biopsy report
15
134
1.12
0.10
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
23
249
0.92
0.10
1.2
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
135
0.89
0.10
1.2
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
36
340
1.06
0.09
1.3
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1504
14985
1.02
0.09
3.9
3.8
mmol/l
1.4
1.3
1.90
1409
13873
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
97
1.13
0.09
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
55
1.09
0.09
2.7
2.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
56
1.07
0.08
1.3
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
33
349
0.94
0.08
1.2
1.1
u/ml
0.2
1.9
2.92
17
147
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
41
390
1.05
0.08
1.3
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
34
359
0.95
0.08
1.1
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
60
0.83
0.08
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
102
993
1.03
0.08
1.6
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
64
1.09
0.08
1.0
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
65
1.08
0.08
1.9
1.7
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
11
123
0.89
0.08
8.2
15.1
nmol/l
521.6
809.6
1.28
11
118
(3047352) Trisomy 18 risk [Likelihood] in Fetus
36
342
1.05
0.08
1.4
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
68
1.03
0.07
6.1
2.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
127
1.10
0.07
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
108
1.11
0.07
1.2
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
7
81
0.86
0.07
2.1
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
84
1.07
0.07
1.6
2.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
79
768
1.03
0.07
1.5
2.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
89
1.12
0.06
5.2
6.6
—
—
—
0
0
(1002224) Polysomnography panel
73
750
0.97
0.06
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
111
0.90
0.06
1.7
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
79
771
1.03
0.05
1.5
2.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
19
178
1.07
0.05
2.1
2.3
pg
34.2
32.1
1.75
19
178
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
21
198
1.06
0.05
1.3
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
78
762
1.02
0.05
1.5
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1567
15639
1.01
0.04
4.3
4.2
mmol/l
4.7
4.7
0.33
1467
14630
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
16
170
0.94
0.04
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1585
15870
0.99
0.04
4.7
4.6
mmol/l
2.8
2.8
0.00
1470
14747
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1553
15549
0.99
0.03
4.3
4.2
mmol/l
1.4
1.5
0.21
1444
14459
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
46
449
1.02
0.03
1.4
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
36
350
1.03
0.03
1.4
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1784
17821
1.01
0.03
26.6
19.1
e9/l
253.8
253.0
0.18
1757
17416
(3051387) C reactive protein [Mass/volume] in Capillary blood
33
321
1.03
0.02
5.3
3.6
mg/l
23.6
24.0
0.02
19
211
(3024731) MCV [Entitic volume]
1785
17833
1.01
0.02
26.4
19.0
fl
90.6
90.7
0.67
1768
17607
(3010726) Horse dander IgE Ab [Units/volume] in Serum
29
298
0.97
0.02
1.1
1.1
u/ml
1.9
2.9
—
7
73
(3002385) Erythrocyte distribution width [Ratio]
1339
13401
1.00
0.01
21.0
15.8
%
13.7
13.6
1.16
1322
13107
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
66
651
1.01
0.01
1.7
1.8
—
—
—
0
0
(3035941) MCH [Entitic mass]
1785
17835
1.01
0.01
26.4
19.0
pg
30.2
30.3
0.84
1768
17607
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
460
4586
1.00
0.01
4.9
4.4
ug/l
2.6
2.3
0.18
420
4134
(3026361) Erythrocytes [#/volume] in Blood
1785
17836
1.01
0.01
26.5
19.1
e12/l
4.5
4.5
1.68
1752
17388
(3050129) First trimester maternal screen panel - Serum or Plasma
52
513
1.01
0.01
1.3
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
126
0.95
0.01
1.2
1.5
g/l
0.9
1.0
0.76
12
126
(3038177) Helicobacter pylori Ab [Presence] in Serum
27
275
0.98
0.00
1.3
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
22
221
1.00
0.00
2.2
2.9
u/ml
3.3
77.7
0.70
22
209
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
185
0.97
0.00
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
55
548
1.00
0.00
1.5
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
410
4096
1.00
0.00
1.6
1.6
mmol/l
1.5
1.4
0.80
357
3487
(3008401) Mugwort IgE Ab [Units/volume] in Serum
30
304
0.99
0.00
1.1
1.1
u/ml
1.8
1.7
0.04
18
132
(3010813) Leukocytes [#/volume] in Blood
1785
17842
1.00
0.00
26.6
19.1
e9/l
6.9
6.7
2.49
1756
17396
(3000963) Hemoglobin [Mass/volume] in Blood
1785
17842
1.00
0.00
26.7
19.2
g/l
135.4
136.6
3.23
1771
17613
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
22
215
1.02
0.00
1.3
1.4
mmol/l
6.8
7.3
0.26
15
156
(44813793)
11
109
1.01
0.00
1.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
49
1.02
0.00
1.2
1.4
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
31.8
—
0
5
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
9
0.00
0.00
0.0
1.0
—
35.6
—
0
9
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
2.6
—
0
6
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
1.5
—
0
7
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
2.0
—
0
7
(3017569) Oxygen content in Arterial blood
7
74
0.95
0.00
2.7
2.8
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint MENINGITIS and mortality.

Females

Parameter HR [95% CI] p-value
MENINGITIS 2.303 [1.99, 2.66] < 0.001
Birth year 0.995 [0.99, 1.0] 0.211

During the follow-up period (1.1.1998 — 31.12.2019), 686 out of 3805 females with MENINGITIS died.

Males

Parameter HR [95% CI] p-value
MENINGITIS 2.327 [2.0, 2.71] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 823 out of 3963 males with MENINGITIS died.

Mortality risk

Mortality risk for people of age

years, who have MENINGITIS.

N-year risk Females Males
1 0.233% 0.438%
5 1.237% 2.553%
10 3.441% 6.493%
15 6.682% 11.706%
20 10.829% 19.098%

Relationships between endpoints

↥

Index endpoint: MENINGITIS – Meningitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data